skip to Main Content

Identification of PGAM1 as a Putative Therapeutic Target for Pancreatic Ductal Adenocarcinoma Metastasis Using Quantitative Proteomics

Newsfeed image, light gray text on dark gray background
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive gastrointestinal cancer characterized by an extremely low survival rate because of early metastasis.

Identifying satisfactory therapeutic targets associated with metastasis is crucial to improve the treatment effect of PDAC. Read more . . . 

Back To Top